Reuters reported that Zimmer Holdings, a medical device manufacturer, is expected to enter into a $12.01 billion credit facility. The article said the financing will support the company’s acquisition of Biomet.

Reuters noted that Credit Suisse is arranging the deal, which comprises a five-year, $1.35 billion revolver; a five-year, $3 billion term loan; and a $7.66 billion, 364-day bridge loan, Reuters said further.

To read the entire Reuters article, click here.